tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co (JP:4521)
:4521

Kaken Pharmaceutical Co (4521) Revenue

Compare
0 Followers

Kaken Pharmaceutical Co Revenue

Kaken Pharmaceutical Co had a revenue of 24.62B in the quarter ending Dec 31, 2024, with -25.67%. This bring the company's revenue in the last twelve months to 93.35B, Decreased 7.00%. In the fiscal year ending Mar 31, 2025, Kaken Pharmaceutical Co had annual revenue of 94.03B with 30.52% growth.
Revenue (ttm)
93.35B
Revenue Growth
30.52%
P/S Ratio
1.48
Revenue/Employee
¥82,850,220
Employees
1,135
Market Cap
¥139.28B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
94.03B21.99B+30.52%
Mar 31, 2024
72.04B-940.00M-1.29%
Mar 31, 2023
72.98B-3.05B-4.01%
Mar 31, 2022
76.03B1.05B+1.41%
Mar 31, 2021
74.98B-14.26B-15.97%
Mar 31, 2020
89.23B-4.93B-5.24%
Mar 31, 2019
94.17B-4.26B-4.33%
Mar 31, 2018
98.43B-3.56B-3.49%
Mar 31, 2017
101.99B-7.23B-6.62%
Mar 31, 2016
109.22B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis